Today I'll offer a stock idea in the genetic research field. Santa Clara, California,-based Affymetrix (AFFX), a leading player and pioneer in developing and selling genomics research analysis equipment, is poised to be an excellent turnaround story. After years of accumulated debt and declining revenues, the company has finally undertaken a long-term strategy for returning to profitability.
It appears to me that Affymetrix is incredibly cheap in light of its turnaround initiative as its restructuring and debt reduction efforts should boost its financial performance significantly going forward. It seems the company is moving in the right direction. I believe the stock could turn out to be a multi-bagger if the turnaround initiative becomes successful, which looks like a...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: